[Macro- and microvascular disease in type 2 diabetes mellitus].
Cases
A
A
D000273:Adipose Tissue / Q000378:metabolism; D009202:Cardiomyopathies / Q000209:etiology / Q000473:pathology; D002318:Cardiovascular Diseases / Q000209:etiology; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D003925:Diabetic Angiopathies / Q000473:pathology*; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology / Q000628:therapy; D006965:Hyperplasia; D006973:Hypertension / Q000209:etiology / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007249:Inflammation; D008019:Life Style; D009765:Obesity / Q000150:complications / Q000503:physiopathology; D018384:Oxidative Stress; D010974:Platelet Aggregation; D015995:Prevalence; D019851:Thrombophilia / Q000209:etiology; D017539:Tunica Intima / Q000473:pathology; D018487:Ventricular Dysfunction, Left / Q000209:etiology / Q000473:pathology
D007004:Hypoglycemic Agents